Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells

Molecules(2024)10.3390/molecules29133189Source: DataRank Database

Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells is a research paper published in Molecules (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.84)OA: goldTopics (54)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Alexander Samokhvalov ORCID,Sheriff Umar ORCID

Live enrichment

PubMed:38999141 OpenAlex:https://openalex.org/W4400320199

National Institute of General Medical Sciences of the National Institutes of Health

Grant: SC3GM136647

National Institutes of Health

Grant: 5SC3GM136647-02

Encapsulation and delayed release of gemcitabine by aluminum metal-organic frameworks

NIH HHS

Grant: 4SC3GM136647-05S5

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1420-3049/29/13/3189/pdf?version=1720090684

publisherhttps://www.mdpi.com/1420-3049/29/13/3189/pdf?version=1720090684

publisherhttps://www.mdpi.com/1420-3049/29/13/3189/pdf

journalhttps://doi.org/10.3390/molecules29133189

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38999141

Fields of Study

Metal-Organic Frameworks: Synthesis and ApplicationsNanoparticle-Based Drug DeliveryGraphene and Nanomaterials Applications02 engineering and technology01 natural sciences0104 chemical sciences0210 nano-technologyGemcitabineDeoxycytidineMetal-Organic FrameworksHumansPancreatic NeoplasmsCell Line, TumorAluminumDrug LiberationDelayed-Action PreparationsPorphyrinsCell SurvivalAntimetabolites, Antineoplastic

MeSH Terms

Metal-Organic FrameworksGemcitabineAluminumAntimetabolites, AntineoplasticCell SurvivalDelayed-Action PreparationsDeoxycytidineHumansPancreatic NeoplasmsPorphyrinsCell Line, TumorDrug Liberation

Keywords

ChemistryDissolutionPorphyrinGemcitabineNuclear chemistryOrganic chemistryAntimetabolites, AntineoplasticPorphyrinsCell Survivalmechano-chemistrymetal-organic frameworkDeoxycytidineArticlePancreatic NeoplasmsDrug LiberationQD241-441pancreatic cancer cellsCell Line, TumorDelayed-Action PreparationsHumansdrug releaseMetal-Organic FrameworksAluminum

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being